ENROFLOXACIN INJECTION, VETERINARY

Solicitation SPE2DP-26-T-5107 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of eight units of Enrofloxacin Injection for veterinary use in dogs. The medication is a 2.27 percent solution (2.5mg/kg) in 20ml containers designed for managing bacterial pathogens. The item is FDA regulated and has a non-extendable shelf life of 24 months. Delivery is required within 81 days after receipt of order, with a required delivery date of September 15, 2026. Inspection and acceptance will occur at the destination, with freight shipping directed to the USA Medical Materiel Center Europe in Germany. The contract mandates strict environmental and quality controls, requiring the product to be protected from direct sunlight, kept from freezing, and stored at or below 25 degrees Celsius, with permitted excursions up to 40 degrees Celsius. Packaging must be commercial and include suitable sealed unit containers and exterior shipping containers. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Compliance with the Buy American Act, the Berry Amendment, and DFARS cybersecurity standards for safeguarding covered defense information is required. All quotes must be submitted via the DLA Internet Bid Board System.